Global Red Biotechnology Market By Product Type (Gene Recombinant Drugs, Human Vaccines, Blood Products, Diagnostic Reagents, Personalized Medicines, Others), By Application (Pharmacogenomics, Gene Therapy, Genetic Testing, Biopharmaceutical Production), By End User (Research Institutes, CMOs & CROs, Biopharmaceutical industries, Others), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: July 2024
- Report ID: 117850
- Number of Pages: 217
- Format:
-
keyboard_arrow_up
-
-
- Pfizer Inc Company Profile
- Merck KGaA Company Profile
- Amgen Inc.
- Novartis AG Company Profile
- Gilead Sciences Inc.
- Takeda Pharmaceutical Company Ltd
- Regeneron Pharmaceuticals Inc.
- AstraZeneca Plc.
- CELGENE Corporation
- settingsSettings
Our Clients
- 117850
- July 2024
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
